Skip to main content

Table 3 Treatment outcome of all seven patients

From: Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma

Number

1stassessment after cycles 1-4

2ndassessment after cycles 5-8

Bevacizumab maintaining times

Radiotherapy (Gy)

3rdassessment

1

CRu

CR

0

40.6

CR

2

CRu

CR

7

40

CR

3

CRu

CR

7

36

CR

4

PD

NAa

0

No

NA

5

CRu

CR

6

42

CR

6

CRu

CR

4

42

CR

7

PR

CRu

0

50

CR

  1. CR: complete remission, CRu: complete remission unconfirmed, PR: partial remission, PD: progressive disease. NA, not assessed. aPatient No. 4 withdrew after the first assessment.